Medical Device Contract Manufacturing Market to Reach US$ 190.88 Billion by 2033 at 10.9% CAGR - Led by Jabil, Thermo Fisher Scientific, and Integer Holdings

Global Medical Device Contract Manufacturing Market reached US$ 76.43 billion in 2024, up from US$ 69.54 billion in 2023, and is expected to reach US$ 190.88 billion by 2033, growing at a CAGR of 10.9% during the forecast period 2025-2033. The market is witnessing steady expansion as medical device companies increasingly rely on third-party manufacturers to meet growing global demand and regulatory requirements.

Market growth is primarily driven by the rising trend of outsourcing among original equipment manufacturers (OEMs) aiming to reduce operational costs, accelerate time-to-market, and concentrate on core research and development activities. In addition, the increasing demand for complex and high-precision medical devices such as cardiovascular implants, orthopedic implants, and advanced diagnostic equipment is pushing OEMs to collaborate with specialized contract manufacturers that offer advanced production technologies, quality compliance, and scalable manufacturing capabilities.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/medical-device-contract-manufacturing-market?sai-v

The Medical Device Contract Manufacturing Market is the sector that provides outsourced design, development, manufacturing, and assembly services for medical device companies to ensure quality, scalability, and regulatory compliance.

Key Developments
✅ December 2025: Medical device OEMs increased outsourcing of end-to-end contract manufacturing services, including design, prototyping, assembly, and sterilization, to improve scalability and reduce time-to-market.

✅ October 2025: Contract manufacturers expanded cleanroom production and advanced automation to meet rising demand for complex implantable, diagnostic, and minimally invasive medical devices.

✅ August 2025: Growing regulatory complexity encouraged OEMs to partner with specialized manufacturers offering integrated quality assurance and compliance management services.

✅ June 2025: Adoption of digital manufacturing tools, including real-time production monitoring and process validation technologies, improved efficiency and traceability across medical device supply chains.

✅ March 2025: Increased demand for wearable and home-use medical devices drove contract manufacturers to enhance capabilities in microelectronics, plastics, and precision machining.

Mergers & Acquisitions
✅ December 2025: A global medical device contract manufacturing company acquired a precision components supplier to strengthen vertical integration and in-house manufacturing capabilities.

✅ October 2025: Strategic partnerships were formed between contract manufacturers and medical device OEMs to support long-term production and product lifecycle management.

✅ August 2025: Contract manufacturing organizations collaborated with automation and robotics firms to improve production consistency and reduce operational costs.

✅ June 2025: Regional contract manufacturers expanded capacity through facility upgrades and joint ventures to serve multinational medical device companies.

✅ March 2025: Industry players entered technical collaborations with material suppliers to develop advanced polymers and metals for next-generation medical devices.

Key Players

DSM | Polaris | Lonza Group Ltd. | Evonik Industries AG | Cellana | Cargill Inc. | Algix | Cyanotech | Corbion Biotech | BASF

Key Players
Jabil Inc. | Thermo Fisher Scientific (PPD) | Integer Holdings Corporation | Sanmina Corporation | Celestica Inc. | Phillips Medisize | Plexus Corp. | Gerresheimer AG

Key Highlights
Jabil Inc. - 18.1%: Leads the market with end-to-end healthcare manufacturing services, strong global scale, and advanced design-to-production capabilities.

Thermo Fisher Scientific (PPD) - 15.4%: Driven by integrated clinical, manufacturing, and life sciences services supporting complex medical device development.

Integer Holdings Corporation - 13.2%: Specializes in medical device outsourcing with expertise in implantable components and high-precision manufacturing.

Sanmina Corporation - 12.1%: Provides advanced electronics manufacturing and supply chain solutions for regulated medical and healthcare markets.

Celestica Inc. - 10.4%: Focuses on high-reliability healthcare electronics and product lifecycle management services.

Phillips Medisize - 9.1%: Known for injection molding, drug delivery systems, and integrated medical device design services.

Plexus Corp. - 7.6%: Offers complex medical electronics manufacturing with strong quality and regulatory compliance capabilities.

Gerresheimer AG - 4.1%: Supports the market through specialty medical packaging, drug delivery components, and pharmaceutical device solutions.

Purchase this report before year-end and unlock an exclusive 30% discount: https://www.datamintelligence.com/buy-now-page?report=medical-device-contract-manufacturing-market?sai-v
(Purchase 2 or more Reports and get 50% Discount)

Market Drivers
- Growing outsourcing of medical device manufacturing to reduce costs and improve scalability.

- Increasing complexity of medical devices requiring specialized manufacturing expertise.

- Rising demand for minimally invasive and technologically advanced medical devices.

- Expansion of regulatory requirements encouraging partnerships with compliant contract manufacturers.

- Growing focus of OEMs on core R&D and product innovation activities.

- Increasing healthcare expenditure and demand for high-quality medical devices.

- Growth of startups and small manufacturers relying on contract manufacturing services.

Industry Developments
- Expansion of end-to-end contract manufacturing services including design, prototyping, and packaging.

- Growing adoption of automation and smart manufacturing technologies in device production.

- Increased investment in cleanroom facilities and advanced quality control systems.

- Rising partnerships between OEMs and contract manufacturers for long-term supply agreements.

- Development of specialized manufacturing capabilities for implantable and combination devices.

- Integration of digital manufacturing and traceability solutions to meet regulatory standards.

- Increased focus on sustainable and cost-efficient medical device manufacturing processes.

Regional Insights
North America - 38% share: "Driven by strong presence of medical device OEMs, advanced manufacturing infrastructure, and high outsourcing adoption."

Europe - 31% share: "Supported by strict regulatory compliance standards, skilled workforce, and growing demand for high-quality medical devices."

Asia Pacific - 26% share: "Fueled by cost-effective manufacturing capabilities, expanding healthcare markets, and rising investments in medical device production."

Latin America - 3% share: "Boosted by emerging manufacturing hubs, increasing medical device demand, and growing foreign investments."

Middle East & Africa - 2% share: "Driven by gradual expansion of medical device manufacturing capabilities and increasing healthcare infrastructure development."

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/medical-device-contract-manufacturing-market?sai-v

Key Segments

➥ By Device Class
Class I Devices: Low-risk medical devices subject to general controls, including basic safety and manufacturing requirements.

Class II Devices: Moderate-risk devices requiring additional regulatory controls, performance standards, and clinical validation to ensure safety and effectiveness.

Class III Devices: High-risk, life-sustaining or life-supporting devices that require rigorous clinical evidence and premarket approval.

➥ By Service Type
Device & Component Manufacturing Services: End-to-end manufacturing of medical devices and components, including design support, prototyping, and large-scale production.

Quality Management Services: Services focused on regulatory compliance, validation, documentation, audits, and quality assurance throughout the product lifecycle.

Packaging & Assembly Services: Specialized services covering sterile packaging, labeling, assembly, and final product preparation in compliance with regulatory standards.

Others: Includes testing, sterilization, logistics, and post-market support services.

➥ By Therapeutic Area
Cardiovascular Devices: Devices used in the diagnosis, monitoring, and treatment of heart and vascular conditions.

Orthopedic Devices: Products designed for musculoskeletal repair, replacement, and mobility restoration.

Ophthalmic Devices: Devices used for vision correction, eye diagnostics, and treatment of ocular disorders.

Respiratory Devices: Equipment used in respiratory care, monitoring, and therapeutic support.

Others: Includes devices for neurology, urology, dental, and additional therapeutic areas.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.